BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26206289)

  • 21. HLA-DR*0401 expression in the NOD mice prevents the development of autoimmune diabetes by multiple alterations in the T-cell compartment.
    Pow Sang L; Surls J; Mendoza M; Casares S; Brumeanu T
    Cell Immunol; 2015; 298(1-2):54-65. PubMed ID: 26363521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 Diabetes.
    James EA; Gillette L; Durinovic-Bello I; Speake C; Bondinas GP; Moustakas AK; Greenbaum CJ; Papadopoulos GK; Kwok WW
    J Immunol; 2018 Dec; 201(12):3524-3533. PubMed ID: 30455401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 1 diabetes induction in humanized mice.
    Tan S; Li Y; Xia J; Jin CH; Hu Z; Duinkerken G; Li Y; Khosravi Maharlooei M; Chavez E; Nauman G; Danzl N; Nakayama M; Roep BO; Sykes M; Yang YG
    Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10954-10959. PubMed ID: 28874533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
    Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
    Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
    Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
    J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
    Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
    Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
    van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
    J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.
    Verbeke CS; Gordo S; Schubert DA; Lewin SA; Desai RM; Dobbins J; Wucherpfennig KW; Mooney DJ
    Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28116870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy.
    Gliwiński M; Iwaszkiewicz-Grześ D; Wołoszyn-Durkiewicz A; Tarnowska M; Żalińska M; Hennig M; Zielińska H; Dukat-Mazurek A; Zielkowska-Dębska J; Zieliński M; Jaźwińska-Curyłło A; Owczuk R; Jarosz-Chobot P; Bossowski A; Szadkowska A; Młynarski W; Marek-Trzonkowska N; Moszkowska G; Siebert J; Myśliwiec M; Trzonkowski P
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32098895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype.
    Durinovic-Belló I; Rosinger S; Olson JA; Congia M; Ahmad RC; Rickert M; Hampl J; Kalbacher H; Drijfhout JW; Mellins ED; Al Dahouk S; Kamradt T; Maeurer MJ; Nhan C; Roep BO; Boehm BO; Polychronakos C; Nepom GT; Karges W; McDevitt HO; Sønderstrup G
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11683-8. PubMed ID: 16868084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells.
    Luo X; Tarbell KV; Yang H; Pothoven K; Bailey SL; Ding R; Steinman RM; Suthanthiran M
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2821-6. PubMed ID: 17307871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
    Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of HLA-DRB1*1501-restricted T-cell epitopes from prostate-specific antigen.
    Klyushnenkova EN; Link J; Oberle WT; Kodak J; Rich C; Vandenbark AA; Alexander RB
    Clin Cancer Res; 2005 Apr; 11(8):2853-61. PubMed ID: 15837732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
    Boitard C
    Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes.
    Gómez-Touriño I; Simón-Vázquez R; Alonso-Lorenzo J; Arif S; Calviño-Sampedro C; González-Fernández Á; Pena-González E; Rodríguez J; Viñuela-Roldán J; Verdaguer J; Cordero OJ; Peakman M; Varela-Calvino R
    Clin Exp Immunol; 2015 May; 180(2):207-17. PubMed ID: 25516468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.
    Ooi JD; Petersen J; Tan YH; Huynh M; Willett ZJ; Ramarathinam SH; Eggenhuizen PJ; Loh KL; Watson KA; Gan PY; Alikhan MA; Dudek NL; Handel A; Hudson BG; Fugger L; Power DA; Holt SG; Coates PT; Gregersen JW; Purcell AW; Holdsworth SR; La Gruta NL; Reid HH; Rossjohn J; Kitching AR
    Nature; 2017 May; 545(7653):243-247. PubMed ID: 28467828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
    Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
    Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulation.
    Engman C; Wen Y; Meng WS; Bottino R; Trucco M; Giannoukakis N
    Clin Immunol; 2015 Sep; 160(1):103-23. PubMed ID: 25773782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.